Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Barrett

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Liver-Targeted SiRNA Delivery Using Biodegradable Poly(amide) Polymer ConjugatesStephanie E Barrett, Erin N Guidry
Pharmaceutics|May 12, 2018
Sustained Release Drug Delivery Applications of PolyurethanesMichael B Lowinger, Stephanie E Barrett, Feng Zhang, et al.
Expert Opinion on Drug Delivery|December 4, 2020
Drug eluting implants in pharmaceutical development and clinical practiceAshley R Johnson, Seth P Forster, David White, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2025
Particle size matters: The impact of particle size on properties and performance of long-acting injectable crystalline aqueous suspensionsJiaying Liu, Ziwan Xu, Di Wu, et al.
Journal of Pharmaceutical Sciences|June 14, 2020
An Imaging Toolkit for Physical Characterization of Long-Acting Pharmaceutical ImplantsDaniel Skomski, Zhen Liu, Yongchao Su, et al.
The AAPS Journal|November 16, 2014
Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primerAnnette Bak, Dennis Leung, Stephanie E Barrett, et al.
Nature Medicine|October 5, 2021
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trialRandolph P Matthews, Munjal Patel, Stephanie E Barrett, et al.
Advanced Healthcare Materials|January 22, 2025
Delivery of Islatravir via High Drug-Load, Long-acting Microarray Patches for the Prevention or Treatment of Human Immunodeficiency VirusQonita Kurnia Anjani, Ashley R Johnson, Akmal H Sabri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 19, 2019
Exploration of long-acting implant formulations of hepatitis B drug entecavirSteven J Henry, Stephanie E Barrett, Seth P Forster, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2022
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 InfectionRandolph P Matthews, Xiaowei Zang, Stephanie E Barrett, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Liver-Targeted SiRNA Delivery Using Biodegradable Poly(amide) Polymer ConjugatesStephanie E Barrett, Erin N Guidry
Pharmaceutics|May 12, 2018
Sustained Release Drug Delivery Applications of PolyurethanesMichael B Lowinger, Stephanie E Barrett, Feng Zhang, et al.
Expert Opinion on Drug Delivery|December 4, 2020
Drug eluting implants in pharmaceutical development and clinical practiceAshley R Johnson, Seth P Forster, David White, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2025
Particle size matters: The impact of particle size on properties and performance of long-acting injectable crystalline aqueous suspensionsJiaying Liu, Ziwan Xu, Di Wu, et al.
Journal of Pharmaceutical Sciences|June 14, 2020
An Imaging Toolkit for Physical Characterization of Long-Acting Pharmaceutical ImplantsDaniel Skomski, Zhen Liu, Yongchao Su, et al.
The AAPS Journal|November 16, 2014
Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primerAnnette Bak, Dennis Leung, Stephanie E Barrett, et al.
Nature Medicine|October 5, 2021
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trialRandolph P Matthews, Munjal Patel, Stephanie E Barrett, et al.
Advanced Healthcare Materials|January 22, 2025
Delivery of Islatravir via High Drug-Load, Long-acting Microarray Patches for the Prevention or Treatment of Human Immunodeficiency VirusQonita Kurnia Anjani, Ashley R Johnson, Akmal H Sabri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 19, 2019
Exploration of long-acting implant formulations of hepatitis B drug entecavirSteven J Henry, Stephanie E Barrett, Seth P Forster, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2022
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 InfectionRandolph P Matthews, Xiaowei Zang, Stephanie E Barrett, et al.
Pageof 2